Uveitis News and Research

RSS
Uveitis is an inflammation of the uvea. The uvea is the front part of the eye. It includes the iris, which is the colored part of the eye, and the parts right next to and behind the iris. Uveitis may hurt a lot of parts of the eye. It may last as long as six weeks, or it may last a shorter time.
Aldose reductase inhibition shows promise for asthma

Aldose reductase inhibition shows promise for asthma

Benfotiamene, a fat-soluble form of vitamin B1, could treat common cause of blindness

Benfotiamene, a fat-soluble form of vitamin B1, could treat common cause of blindness

Columbia University licenses retinal imaging technology to PCAsso Diagnostics

Columbia University licenses retinal imaging technology to PCAsso Diagnostics

Bad mix of bacterial remnants and NOD2 gene lead to arthritis

Bad mix of bacterial remnants and NOD2 gene lead to arthritis

SARcode announces results of phase 1 trial of SAR 1118 ophthalmic solution in healthy adult subjects

SARcode announces results of phase 1 trial of SAR 1118 ophthalmic solution in healthy adult subjects

Positive phase 3 uveitis trial results for voclosporin

Positive phase 3 uveitis trial results for voclosporin

Sirion Therapeutics sNDA for Durezol to treat uveitis accepted for FDA review

Sirion Therapeutics sNDA for Durezol to treat uveitis accepted for FDA review

New technique to watch for eye disease

New technique to watch for eye disease

New imaging technique captures clinical stages of ocular inflammation

New imaging technique captures clinical stages of ocular inflammation

FDA approves Actonel (risedronate sodium) for postmenopausal osteoporosis

FDA approves Actonel (risedronate sodium) for postmenopausal osteoporosis

Age Intervention Eyelash products seized by U.S. Marshals

Age Intervention Eyelash products seized by U.S. Marshals

Eyelash growth product can damage vision

Eyelash growth product can damage vision

Potential new therapy for uveitis

Potential new therapy for uveitis

Sirion Therapeutics starts phase III clinical trials of pipeline compounds

Sirion Therapeutics starts phase III clinical trials of pipeline compounds

Aston Academy investigates macular oedema

Aston Academy investigates macular oedema

Immunosuppressive drug mycophenolate mofetil may be effective in controlling inflammatory eye diseases

Immunosuppressive drug mycophenolate mofetil may be effective in controlling inflammatory eye diseases

New treatment improves visual acuity score of patients with retinitis pigmentosa

New treatment improves visual acuity score of patients with retinitis pigmentosa